News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Aug 31, 2023, 19:04

Naveen Pemmaraju: Ph2 CLIA with or without sorafenib for upfront AML therapy.

Naveen Pemmaraju, the Executive Director of Cancer Medicine at the MD Anderson Cancer Center, recently tweeted:

“Brand new paper alert from our group Ph2 CLIA with or without sorafenib for upfront AML therapy led by Tapan Kadia, Hagop Kantarjian, Gautam Borthakur, Naval Daver, Naveen Pemmaraju, Nitin Jain and Musa Yilmaz.”

For the article click here.
Source: Naveen Pemmaraju/Twitter

Naveen Pemmaraju: Ph2 CLIA with or without sorafenib for upfront AML therapy.

cancer Gautam Borthakur Hagop Kantarjian Musa Yilmaz Naval Daver Naveen Pemmaraju Nitin Jain OncoDaily Oncology Research sorafenib Tapan Kadia Twitter
Special Coverage
Blog
May 4, 2025, 13:12
Luis A. Pérez-Romasanta: DART phase II trial results
Blog
May 4, 2025, 12:59
Mark Bolton: SKAGEN-1 - Breast Cancer Mortality by Treatment arm
Drugs
May 4, 2025, 12:58
Agenus suports Richard Goldberg’s call for evolving drug development models
Blog
May 4, 2025, 12:45
Pierre Blanchard Highlights SBRT as New Option for Small Oral Cavity Cancers
Blog
May 4, 2025, 12:41
Francesco Massari highlights ARON Project at Brown University’s GU translational research meeting
Blog
May 4, 2025, 12:33
Giulio Francolini: QoL data from DART trial
Science
May 4, 2025, 12:21
Breast Cancer in Young patients at ESTRO 2025: The Impact of BRCA-carriership on indications for RT
Science
May 4, 2025, 11:47
Breast Cancer in Young patients at ESTRO 2025: Reproductive issues in young BRCA carriers affected by breast cancer
Insight
May 4, 2025, 11:45
Sergio Cifuentes highlights key limitations of the PLATFORM study on esophagogastric adenocarcinoma
Insight
May 4, 2025, 11:29
STELLAR II trial at ESTRO 2025: Immunotherapy Combined with Radiotherapy and Chemotherapy Reduces the Need for Surgery in Locally Advanced Rectal Cancer
Blog
May 4, 2025, 11:26
Collaboration between National Societies and Patients can Strengthen Advocacy - ESTRO
Blog
May 4, 2025, 11:14
Marie-Catherine Vozenin Honored with Claudius Regaud Award at ESTRO 2025